Chris Lewis
Vice President of Investor Relations and Corporate Affairs
Replay available
Glaukos Corporation (NYSE: GKOS) Q1 2026 earnings conference call, held 2026-04-29. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations and Corporate Affairs
Chairman and CEO
President and COO
Chief Financial Officer
Analyst, Stifel
Analyst, Piper Sandler
Analyst, Wells Fargo Securities
Analyst, BTIG
Analyst, Goldman Sachs
Analyst, J.P. Morgan
Analyst, Needham & Company
Analyst, Jefferies
Analyst, Citi
Analyst, William Blair
Analyst, Mizuho Securities
Welcome to Glowcoast Corporation's first quarter 2026 financial results conference call. Copies of the company's press release and quarterly summary document, both issued after the market closed today, are available at www.glowcoast.com. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. To ask a question, simply press star 1 on your telephone keypad. To withdraw your question, press star 1 again. This call is being recorded, and an archived replay will be available online in the Investor Relations section at www.gloukos.com. I will now turn the call over to Chris Lewis, Vice President of Investor Relations and Corporate Affairs. Thank you, and good afternoon. Joining me today are Glocko's Chairman and CEO, Tom Burns, President and COO, Joe Gilliam, and CFO, Alex Thurman. Similar to prior quarters, the company has posted a document on its investor relations website under the Financials and Filings Quarterly Results section titled Quarterly Summary. This document is designed to be read by investors before the regularly scheduled quarterly conference call. To ensure ample time and opportunity to address everyone's questions, we request that you limit yourself to one question and one follow-up. you still have additional questions, you may get back into the queue. Please note that all statements, other than statements of historical factors made on this call, address activities, events, or developments we expect, believe, or anticipate will or may occur in the future are forward-looking statements. These include statements about our plans, objectives, strategies, and prospects regarding, among other things, for sales, products, pipeline technologies, and clinical trials, U.S. and in...